Background Although experimental and clinical evidences suggest that endothelin-1 ET-1 may play a pathophysiological role in ischemic heart disease, it is still controversial whether ET-1 produced during myocardial ischemia and reperfusion affects the extent of necrotic myocardium. This study was performed to investigate the role of ET-1 and the effect of ET antagonists in infarct size determination.
Conclusion ET-A antagonist FR139317, given throughout reperfusion, did not reduce myocardial infarct size in rat. Bosentan ET-A/ET-B antagonist given just before coronary occlusion as i.v. bolus also did not reduce myocardial infarct size in rat. 
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